Clinical characteristics and practice patterns of type 2 diabetes mellitus (T2DM) patients treated with oral antidiabetic drugs (OAD) in Japan: analysis of medical and health care database of the Medical Data Vision (MDV)

Study identification

• EU PAS number:
  EUPAS17761
• Study ID:
  25010
• Official title and acronym:
  Clinical characteristics and practice patterns of type 2 diabetes mellitus (T2DM) patients treated with oral antidiabetic drugs (OAD) in Japan: analysis of medical and health care database of the Medical Data Vision (MDV)
• DARWIN EU® study:
  No
• Study countries:
  Japan
• Study description:
  Appropriate use of oral antidiabetic drugs (OADs) including dose-reduction is important for patient’s safety in T2DM patients with renal impairment (RI). However, there are insufficient data on dose adjustment in accordance with the prescription pattern and the risk of RI of OADs, in particular DPP-4 inhibitors, in clinical practice in Japan. Therefore, we will investigate OADs usage conditions and dose selection in T2DM patients with RI in clinical practice in Japan
• Study status:
  Finalised

Research institutions and networks

Institutions

Boehringer Ingelheim

Study timelines

Date when funding contract was signed

Planned: 01/08/2016

Actual: 01/08/2016

Study start date

Planned: 01/03/2017

Actual: 01/03/2017

Data analysis start date

Planned: 10/03/2017

Actual: 10/03/2017

Date of final study report

Planned: 01/08/2018

Actual: 23/07/2018

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Nippon Boehringer Ingelheim Co., Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable